AURINIA PHARMACEUTICALS INC-

AURINIA PHARMACEUTICALS INC- Share · CA05156V1022 · AUPH · A1W7D4 (XTSX) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of AURINIA PHARMACEUTICALS INC-
No Price
01.05.2026 20:00
Current Prices from AURINIA PHARMACEUTICALS INC-
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
AUPH
USD
01.05.2026 20:00
15,35 USD
-0,04 USD
-0,23 %
IEXG: IEX
IEX
AUPH
USD
01.05.2026 19:59
15,36 USD
-0,03 USD
-0,19 %
XDUS: Düsseldorf
Düsseldorf
APIRSN22.DUSB
EUR
30.04.2026 17:31
13,11 EUR
-0,46 EUR
-3,43 %
XDQU: Quotrix
Quotrix
APIRSN22.DUSD
EUR
30.04.2026 05:27
12,99 EUR
-
Invested Funds

The following funds have invested in AURINIA PHARMACEUTICALS INC- :

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
74,74
Percentage (%)
0,18 %
Company Profile for AURINIA PHARMACEUTICALS INC- Share
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

Company Data

Name AURINIA PHARMACEUTICALS INC-
Company Aurinia Pharmaceuticals Inc.
Symbol AUPH
Website https://www.auriniapharma.com
Primary Exchange XTSX TSX-V
WKN A1W7D4
ISIN CA05156V1022
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Peter S. Greenleaf
Market Capitalization 2 Mrd.
Country Canada
Currency USD
Employees 0,1 T
Address 4464 Markham Street, V8Z 7X8 Edmonton
IPO Date 2014-09-03

Stock Splits

Date Split
23.10.2013 1:50

Ticker Symbols

Name Symbol
Düsseldorf APIRSN22.DUSB
Frankfurt IKAP.F
NASDAQ AUPH
Quotrix APIRSN22.DUSD
More Shares
Investors who hold AURINIA PHARMACEUTICALS INC- also have the following shares in their portfolio:
AAREAL BANK MTN S.265
AAREAL BANK MTN S.265 Bond
AMGEN INC
AMGEN INC Share
APPLIED MATERIALS INC
APPLIED MATERIALS INC Share
AUTODESK INC
AUTODESK INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
CREDIT SUISSE GROUP AG
CREDIT SUISSE GROUP AG Share
INTEL CORP
INTEL CORP Share
INTUIT INC
INTUIT INC Share
MICROSOFT CORP
MICROSOFT CORP Share
MONSTER BEVERAGE CORP
MONSTER BEVERAGE CORP Share
NORDLB 19/28
NORDLB 19/28 Bond
UNIEURORENTA CORPR.A
UNIEURORENTA CORPR.A Fund
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share